Clinical Trial

Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 24, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
To observe and evaluate the neoadjuvant treatment of Envafolimab combined with Fruquintinib and chemotherapy for locally advanced gastric/gastroesophageal junction carcinoma
Trial Details
NCT Number NCT06791083
Lead Sponsor First Affiliated Hospital of Fujian Medical University
Conditions Gastric Cancer
Enrollment 40 participants
Start Date 2024-06-20
Primary Completion 2025-12 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2025-01-24